Corneal remodelling system developer Avedro boosted its total funding to more than $220m with a round led by Lilly Asia Ventures.

Biopharmaceutical product manufacturer 3SBio co-led the cancer therapy developer's series B round, which included WuXi Healthcare Ventures.

GV and existing investor Salesforce Ventures were among the participants in a series B round that lifted the text messaging platform's total funding to $42m.

Cambridge Epigenetix has now raised $56.5m from investors including the university and Alphabet’s GV for its epigenetics-powered diagnostic platform.

The IoT integration platform developer boosted its overall funding to $63m in a Salesforce Ventures-led round featuring IBM.

The Johnson & Johnson-backed cardiac medical device developer has completed a series B round that will fund clinical tests for its technology.

SoftBank Ventures Korea and CE Ventures added $10m to the sports analytics technology developer's Verizon-backed first close last June.

The beauty retailer added $11.2m to a round now sized at $25.5m, on the heels of 2016 investments from Max Group and TCL.

The insurance management platform, backed by ProSiebenSat.1 and Axel Springer at series A stage, has now raised $45m altogether.

Amazon has supplied $22m to help the business lending platform boost its latest round to $67m and its overall funding to almost $110m.